These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1281852)

  • 41. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
    Ferrari R; Merli E; Cicchitelli G; Mele D; Fucili A; Ceconi C
    Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
    Hamed SA; Abdella MM
    Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship of carnitine and carnitine precursors lysine, epsilon-N-trimethyllysine, and gamma-butyrobetaine in drug-induced carnitine depletion.
    Melegh B; Pap M; Bock I; Rebouche CJ
    Pediatr Res; 1993 Oct; 34(4):460-4. PubMed ID: 8255678
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carnitine metabolism and deficiency syndromes.
    Rebouche CJ; Engel AG
    Mayo Clin Proc; 1983 Aug; 58(8):533-40. PubMed ID: 6348429
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carnitine deficiency in epilepsy: Risk factors and treatment.
    Coulter DL
    J Child Neurol; 1995 Nov; 10 Suppl 2():S32-9. PubMed ID: 8576567
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Antiepileptic drugs and carnitine].
    Campistol J; Chávez B; Vilaseca MA; Artuch R
    Rev Neurol; 2000 Jun; 30 Suppl 1():S105-9. PubMed ID: 10904975
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myocardial function, energy provision, and carnitine deficiency in experimental uremia.
    Reddy V; Bhandari S; Seymour AM
    J Am Soc Nephrol; 2007 Jan; 18(1):84-92. PubMed ID: 17182887
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potential relationships between transaminase abnormality and valproic acid clearance or serum carnitine concentrations in Japanese epileptic patients.
    Goto S; Seo T; Hagiwara T; Ueda K; Yamauchi T; Nagata S; Ando Y; Ishitsu T; Nakagawa K
    J Pharm Pharmacol; 2008 Feb; 60(2):267-72. PubMed ID: 18237476
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carnitine in the treatment of valproic acid-induced toxicity.
    Lheureux PE; Hantson P
    Clin Toxicol (Phila); 2009 Feb; 47(2):101-11. PubMed ID: 19280426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Valproate-induced coma with ketosis and carnitine insufficiency.
    Triggs WJ; Bohan TP; Lin SN; Willmore LJ
    Arch Neurol; 1990 Oct; 47(10):1131-3. PubMed ID: 2121122
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carnitine deficiency.
    Hunt PA; Pellock JM
    Pediatrics; 1995 Dec; 96(6):1175; author reply 1176. PubMed ID: 7491249
    [No Abstract]   [Full Text] [Related]  

  • 52. Carnitine deficiency.
    McCurdy HT
    Pediatrics; 1995 Dec; 96(6):1174-5; author reply 1176. PubMed ID: 7491248
    [No Abstract]   [Full Text] [Related]  

  • 53. Systemic carnitine deficiency. Report of a fatal case with multisystemic manifestations.
    Ware AJ; Burton WC; McGarry JD; Marks JF; Weinberg AG
    J Pediatr; 1978 Dec; 93(6):959-64. PubMed ID: 722440
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Secondary carnitine deficiency].
    Kuwajima M
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():706-9. PubMed ID: 12013978
    [No Abstract]   [Full Text] [Related]  

  • 55. Exacerbation of mood symptoms associated to primary and secondary carnitine deficiency: a case report.
    Santos-Cubiñá J; Torres-Rodríguez A; Castaing-Lespier PA; Sabaté N; Torres-Martin A; Carlo S
    Bol Asoc Med P R; 2013; 105(3):43-4. PubMed ID: 24282920
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A severe disabled case of incomplete Fanconi syndrome after discontinuation of carnitine supplementation during valproate sodium therapy].
    Ono H
    No To Hattatsu; 2007 May; 39(3):226-7. PubMed ID: 17515139
    [No Abstract]   [Full Text] [Related]  

  • 57. Carnitine-dependent changes of metabolic fuel consumption during long-term treatment with valproic acid.
    Melegh B; Pap M; Morava E; Molnar D; Dani M; Kurucz J
    J Pediatr; 1994 Aug; 125(2):317-21. PubMed ID: 8040784
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A case report of valproate encephalopathy].
    Miyamoto T; Miyamoto M; Hirata K; Katayama S
    Rinsho Shinkeigaku; 1999 Oct; 39(10):1075-7. PubMed ID: 10655774
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of carnitine and fatty acid oxidation and its defects in infantile epilepsy.
    Tein I
    J Child Neurol; 2002 Dec; 17 Suppl 3():3S57-82; discussion 3S82-3. PubMed ID: 12597056
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of carnitine on valproic acid concentrations in serum, brain, and liver.
    Sakemi K; Takada G
    Pediatr Neurol; 1998 Apr; 18(4):331-3. PubMed ID: 9588529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.